It remains an investigational compound, developed by Eli Lilly and Company, and is currently undergoing Phase 3 clinical trials evaluating its safety and efficacy in adults with obesity and type 2 diabetes
Access to real-time adverse event data may permit safety signal trends to be identified earlier, which could in turn lead to more efficient manufacturer corrective actions (or quicker agency enforcement action) to prevent further harm to patients or the public health
And knowing how many milligrams common unit measurements represent prevents basic calculation errors
Dont stop taking Prozac without first consulting with your healthcare practitioner, because stopping the medication suddenly can cause negative side effects (i.e., headache, numbness, insomnia, etc.)
PMID: 23334697 LaRusch J, Jung J, General I.J, Lewis M.D, Park H.W, Brand R.E, Gelrud A, Anderson M.A, Banks P.A, Conwell D, Lawrence C, Romagnuolo J, Baillie J, Alkaade S, Cote G, Gardner T.B, Amann S.T, Slivka A, Sandhu B, Aloe A, Kienholz M.L, Yadav D, Barmada M.M, Bahar I, Lee M.G, Whitcomb D.C, and the North American Pancreatology Study Group
It's important to note that this risk is not unique to tirzepatide